|
|
||||||||
Ann Thorac Surg 2002;74:S1371-S1376
© 2002 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea
b Department of Anesthesiology, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea
* Address reprint requests to Dr Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, 28 Yeun-Kun Dong, Chong-Ro Ku, Seoul 110-744, South Korea
e-mail: kimkb{at}snu.ac.kr
Presented at the Eighth Annual Cardiothoracic Techniques and Technologies Meeting 2002, Miami Beach, FL, Jan 2326, 2002.
| Abstract |
|---|
|
|
|---|
Methods. A total of 223 consecutive patients who underwent OPCAB using bilateral skeletonized ITAs as Y grafts (group I, n = 113) or in situ grafts (group II, n = 110) were studied.
Results. Both the number of distal anastomoses per patient and the number of distal anastomoses per bilateral ITA were higher in group I (3.5 ± 1.0 and 2.9 ± 0.7) than in group II (3.0 ± 0.7 and 2.4 ± 0.5) (p < 0.01). Hospital mortality was 1.8% (2/113) in group I and 0.9% (1/110) in group II (p = ns). There were no differences in postoperative complications including atrial fibrillation (13.3% vs 10.9%), perioperative myocardial infarction (0.9% vs 2.7%), mediastinitis (0.9% vs 1.8%), and hypoperfusion syndrome (0.9% vs 0%) between groups I and II (p = ns). Postoperative coronary angiographies performed in 110 patients in group I and 108 patients in group II showed 99.0% (382/386) overall patency and 99.4% (319/321) patency for distal anastomoses using ITAs in group I, and 98.1% (312/318) overall patency and 98.1% (258/263) patency for distal anastomoses using ITA in group II. There were no significant differences in graft patency rates between the two groups (p = ns).
Conclusions. Our results demonstrate that OPCAB using bilateral skeletonized ITAs is technically feasible, with excellent graft patency. Using bilateral skeletonized ITAs as Y grafts increases the number of distal anastomoses that can be performed and does not cause additional postoperative morbidity.
| Introduction |
|---|
|
|
|---|
The aims of this study were: 1) to assess the feasibility of OPCAB using bilateral skeletonized ITAs, and 2) to compare the early results after OPCAB using bilateral ITAs as either Y or in situ grafts.
| Patients and methods |
|---|
|
|
|---|
|
A standard skeletonizing technique for harvesting the ITA was used in all patients. We routinely opened the pleura before ITA dissection to facilitate exposure. To avoid thermal injury to the ITA, the cautery setting was kept on low throughout the dissection. Cautery was used to cut the endothoracic fascia and to expose the underlying ITA. Using scissors or the tip of the cold cautery device for dissection, the ITA was gently separated from the chest wall, leaving the accompanying veins, fascia, and adipose tissue in place. The sternal and intercostal branches were clipped just after the origin and divided between the two silver clips using scissors. Care was taken to avoid any damage to the sites of branch origin to prevent dissection of the ITA. Throughout the dissection, the ITA was sprayed with warm diluted papaverine solution to minimize spasm and to prevent desiccation. If using bilateral ITAs as in situ or Y grafts did not achieve complete revascularization, a short lower extension of the median incision was made to harvest the right gastroepiploic artery in a skeletonized fashion. If significant narrowing of the celiac axis was found on the preoperative abdominal aortogram or if there was a past medical history of upper abdominal surgery, the radial artery or saphenous vein graft (SVG) was harvested instead. After systemic heparinization, the ITAs were clipped distally. The skeletonized grafts were then immersed in a 10-mL syringe filled with warm diluted papaverine saline solution (1 mg/mL) and allowed to pharmacologically dilate. The ITA was immersed for 5 to 10 minutes in the syringe vertically embedded in the open pleural cavity. We did not use intraluminal injection of papaverine solution.
OPCAB technique
The patients were heparinized with an initial dose of 1.5 mg/kg of heparin, and periodically received supplemental doses to maintain an activated clotting time of more than 300 seconds. One or two supplemental doses of heparin were required during the OPCAB procedure. After the pericardium was opened and the right pleuropericardial fat pads transected, two deep pericardial sutures were placed to facilitate pericardial retraction for cardiac elevation and exposure. To reduce the heart rate to less than 70 to 80 beats per minute and to minimize myocardial oxygen consumption, most of the patients were given boluses or continuous infusion of ß-blockers such as esmolol or adenosine. Ischemic preconditioning was not performed in most of the cases. Anesthesia management, including volume loading and placing the patient in the Trendelenburg position, controlled hemodynamic derangement during displacement or manipulation of the heart. To reduce the amplitude of ventricular wall movement, a compression-type mechanical stabilizer (Ultima Stabilizer; Guidant, Cupertino, CA) or suction-type mechanical stabilizer (Octopus; Medtronic, Minneapolis, MN) was used. To obtain a bloodless operative field, internal vascular control was achieved with a flow occluder (Florester, Bio-Vascular Inc, Saint Paul, MN) or intracoronary shunt (FloCoil Shunt; Guidant, Cupertino, CA). A Blower/Mister (Visuflo; Baxter Healthcare, Midvale, UT) using carbon dioxide gas (flow rate
3 L/min) or a microsucker system with a rubber tip was also used to obtain a bloodless surgical field. The most critical vessel, the LAD in almost all patients, was revascularized first to provide a backup to the less critical area. The distal anastomosis was constructed using a continuous technique with 8-0 polypropylene sutures. If needed, proximal anastomoses on the ascending aorta were constructed after distal anastomoses, using a single partial clamping of the aorta and a 7-0 polypropylene continuous suture. Protamine was not given at the end of the procedure.
Revascularization strategies
Bilateral ITAs were preferred for use as in situ grafts for myocardial revascularization on the assumption that multiple blood sources would be better than a single blood source to improve long-term outcome. Both ITAs were used when possible for revascularization of the left coronary territory. The right ITA was used to revascularize the LAD by crossing the midline, the ramus or high obtuse marginal branch through the transverse sinus, and sometimes the right coronary artery or posterior descending artery as an in situ graft. If the right ITA was too short to reach the left coronary territory or if the left coronary territory could not be completely revascularized with bilateral in situ ITA grafts, a Y graft was constructed before starting the distal anastomoses. In most cases of Y graft construction, the right ITA was divided at its proximal section and was anastomosed to the side of the left ITA in a Y fashion using an 8-0 polypropylene continuous suture. Most of these end-to-side Y anastomoses were performed at the level of the pulmonary artery, and occasionally the right ITA was anastomosed to the distal left ITA unless it reached an optimal vessel such as the right coronary territory. If use of the bilateral ITAs as in situ or Y grafts did not achieve complete revascularization, the right gastroepiploic artery, radial artery, or saphenous vein was used for additional revascularization.
Statistical analysis
Statistical analysis was performed with the Statistical Analysis System software package (version 6.12; SAS Institute, Cary, NC). The significance of differences between the two groups was assessed by the unpaired two-tailed t test or
2 test. All results were expressed as mean ± standard deviation, and a p value of less than 0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
Postoperative coronary angiographies demonstrated a 99.0% patency rate in group I and 98.1% in group II. There were no differences in graft patency rates between the two groups (p = ns) (Table 5).
|
| Comment |
|---|
|
|
|---|
Enhanced long-term survival has been shown when the left ITA is grafted to the LAD rather than the SVG, or when bilateral ITAs are used rather than a single ITA in patients with triple-vessel disease [1, 4]. The skeletonized technique for harvesting the ITA allowed easier use of bilateral ITAs with good results [5, 6]. Those results have provided the foundation for using more arterial conduits to achieve complete myocardial revascularization. With resurgent interest in OPCAB, there have been concerns about accuracy and patency of the grafts and the long-term outcome. Ömeroglu and associates [7] demonstrated a significantly lower patency rate for SVG (47.1%) than for ITA (95.7%) in 3-year follow-up results after OPCAB. They suggested that the decreased patency rate for SVG might result in part from the type of graft, and the exposure and quality of stabilization during OPCAB. Regional cardiac wall immobilization with specially designed stabilizer systems provides excellent stabilization of the target area, enables surgeons to perform coronary anastomoses safely without cardiopulmonary bypass, and greatly enhances graft patency in a predictable manner [8]. Mariani and associates [9] demonstrated that procoagulant activity was increased in the first 24 hours after OPCAB, and suggested not antagonizing the heparin with protamine at the end of the procedure, along with more aggressive perioperative anticoagulation policy for patients undergoing OPCAB than that for patients undergoing conventional CABG with cardiopulmonary bypass. Kim and colleagues [10] also demonstrated that the patency rate of saphenous vein graft after OPCAB was significantly lower than that of arterial grafts as seen in early postoperative coronary angiographies, and was also significantly lower than the saphenous vein graft patency rates for conventional CABG and on-pump beating CABG as seen in 1-year postoperative coronary angiographies. They suggested not antagonizing the heparin with protamine at the end of the OPCAB procedure, and performing the OPCAB using exclusively arterial grafts to avoid the low patency rate and sequelae of saphenous vein graft occlusion. However, technical difficulties and lack of angiographic results make surgeons hesitant to perform OPCAB using multiple arterial grafts. Mack and associates [11] reviewed publications that examined outcomes of left ITA grafting in conventional CABG and minimally invasive direct CABG. They suggested that early graft patency after both techniques could confidently be stated as being 90% or greater. Calafiore and associates [12] demonstrated the feasibility of arterial revascularization without cardiopulmonary bypass, with results similar to those obtained with cardiopulmonary bypass. They showed a 98.9% patency rate of arterial grafts at about 1 month after OPCAB. Postoperative coronary angiographies were performed in the present study 1.3 ± 1.0 days postoperatively. These data showed that the patency rate for distal anastomoses using bilateral ITAs was 99.4% (319/321) in patients with Y grafts and 98.1% (256/261) in patients with in situ grafts (p = ns), demonstrating excellent early patency comparable to those of recent reports [11, 12], and suggested the feasibility OPCAB using bilateral skeletonized ITAs.
Although using bilateral skeletonized ITAs increases the difficulty and duration of the operation, it retains several advantages that may eventually result in better long-term outcomes for patients. The advantages of bilateral skeletonized ITA dissection are that the dissected ITA is longer and that its spontaneous blood flow is greater than that of the pedicled ITA [13], allowing use of both ITAs as grafts to all necessary vessels requiring surgical revascularization. Additional advantages are that collateral blood supply to the sternum is preserved, enabling more rapid healing and decreasing the risk of deep sternal infection [14]. The use of bilateral ITAs as in situ grafts for myocardial revascularization was preferred in the present study based on the belief that multiple blood sources may be better than a single blood source for improving long-term outcome. However, using bilateral ITAs as in situ grafts sometimes does not achieve complete arterial revascularization for patients with multivessel coronary disease. If the right ITA was too short to reach the left coronary system, or if the left coronary system could not be completely revascularized with bilateral in situ ITA grafts, the right ITA was divided at its proximal part to construct a Y graft. Construction of a Y graft further increases the length of the skeletonized ITA, and allows the extensive use of bilateral ITA grafts to revascularize the left coronary system as well as the right coronary system [15]. The present study showed that the number of distal anastomoses per bilateral ITA was 2.9 ± 0.7 in patients with Y grafts and 2.4 ± 0.5 in patients with in situ grafts, demonstrating greater versatility of Y grafts compared with in situ grafts (p < 0.01). Although construction of Y grafts has shown an increase in total ITA free flow [16], there is a concern that graft flow may be inadequate, resulting in a hypoperfusion syndrome manifested by low cardiac output, left ventricular failure, increasing pulmonary wedge pressure, hypotension, and cardiac arrest [17]. There was no low cardiac output syndrome in patients with Y grafts or in situ grafts. There was only one case of hypoperfusion syndrome in a patient with Y grafts, not a significant difference in the incidence of hypoperfusion syndrome between patients with Y grafts and in situ grafts. We believe that our low incidence of low cardiac output syndrome or hypoperfusion syndrome may result from the OPCAB technique, by avoiding intraoperative myocardial ischemia, as well as from our method of meticulous ITA dissection and pharmacological ITA dilatation to minimize surgical trauma and perioperative spasm of the ITA.
Multiple retrospective clinical studies have documented an increased risk of sternal wound complication associated with bilateral ITA grafting, particularly in diabetic patients [18]. The increased risk of wound complications appears to be caused by sternal ischemia. One anatomic study predicted a decrease in sternal blood flow resulting from ITA dissection [19], and postoperative flow studies have confirmed that sternal blood flow is decreased postoperatively by ITA dissection, more after bilateral ITA grafting than after single ITA grafting [20]. The skeletonized ITA dissection leaves those accompanying veins, muscle, and endothoracic fascia in place and preserves the collateral blood supply to the sternum, enabling more rapid healing and decreasing the risk of infection. De Jesus and Acland [19] suggested that all ITA branches be ligated as close as possible to the main vessel trunk to minimize damage to the collateral blood supply of the sternum. Studies of bilateral skeletonized ITA graftings have demonstrated similar incidences of deep sternal infection in elderly and diabetic patients, and using bilateral skeletonized ITAs is suggested as a good surgical revascularization option even in elderly or diabetic patients [5, 6]. The present study showed that the postoperative incidence of mediastinitis was 0.9% in patients with Y grafts and 1.8% in patients with in situ grafts, demonstrating comparable results with previous studies.
In conclusion, OPCAB using bilateral skeletonized ITAs is feasible and demonstrates excellent early graft patency. Using bilateral skeletonized ITAs as Y grafts increased the number of distal anastomoses that could be performed and did not increase operative morbidity, compared with those of in situ grafts.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K.-B. Kim, K. R. Cho, and D. S. Jeong Midterm angiographic follow-up after off-pump coronary artery bypass: serial comparison using early, 1-year, and 5-year postoperative angiograms. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Cho, D. S. Jeong, and K.-B. Kim Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 718 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukui, S. Takanashi, Y. Hosoda, and S. Suehiro In situ bilateral skeletonized internal thoracic arterial grafting for left-side myocardial revascularization using an off-pump technique Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 413 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Raja and G. D. Dreyfus Internal Thoracic Artery: To Skeletonize or Not to Skeletonize? Ann. Thorac. Surg., May 1, 2005; 79(5): 1805 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hyun Kang, K.-B. Kim, C. Soo Park, J. Chul Paeng, and D. Soo Lee Improvement of Myocardial Stress Perfusion After Off-Pump Revascularization Using Bilateral Internal Thoracic In Situ Grafts Versus Y-Composite Grafts Ann. Thorac. Surg., January 1, 2005; 79(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamiya, G. Watanabe, H. Takemura, S. Tomita, H. Nagamine, and T. Kanamori Skeletonization of gastroepiploic artery graft in off-pump coronary artery bypass grafting: early clinical and angiographic assessment Ann. Thorac. Surg., June 1, 2004; 77(6): 2046 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Athanasiou, M.-C. Crossman, G. Asimakopoulos, A. Cherian, A. Weerasinghe, B. Glenville, and R. Casula Should the internal thoracic artery be skeletonized? Ann. Thorac. Surg., June 1, 2004; 77(6): 2238 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamiya, G. Watanabe, H. Takemura, S. Tomita, H. Nagamine, and T. Kanamori Total arterial revascularization with composite skeletonized gastroepiploic artery graft in off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |